Previous applications of TUS were limited, as they were imprecise and too weak to target areas deeper in the brain. Parkinson ...
February 2024: Servier announced FDA acceptance and priority review of the NDA for vorasidenib, which could become the first ...
LLMs and the Brain, a symposium featuring researchers from Rice, Baylor College of Medicine, the University of Texas, the Georgia Institute of Technology, the University of Montreal and other ...
Neuralink has moved to validate its controversial brain-implant technology in the scientific arena by submitting its first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results